SecBot SecBot
8-K ·Filed Nov 3, 2026

GH

Guardant Health, Inc.
NEUTRAL
Impact 2/10
Horizonmonths Processed13d 17h ago SEC0001193125-26-444416
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor Guardant Health's relative TSR performance against the S&P 500 over the next 3-5 years to assess potential dilution from PSU vesting. No immediate trading catalyst from this filing.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$175.00
T+0 close · Nov 3, 2026 · via day close
Latest settled
−11.23%
T+5 · $155.35 · next T+20 in 15d
Vs SPY
−10.64%
α at T+5
Latest observation
−11.74%
T+8 · FF3 residual α
  1. T+0 · Nov 3 $175.00entry
  2. T+1 · 13d ago −3.67%α −5.32% · $168.58
  3. T+5 · 7d ago −11.23%α −10.64% · $155.35
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Guardant Health granted 465,413 performance-based restricted stock units (PSUs) at target to each of its co-CEOs, Helmy Eltoukhy and AmirAli Talasaz, under the 2018 Incentive Award Plan. The PSUs are 100% performance-based, tied to the company's total shareholder return relative to the S&P 500 over three-year and five-year periods, with post-vest holding requirements. This is a routine compensatory arrangement for continuing executives with no departure or appointment.

Key Facts

  • Each co-CEO received 465,413 target PSUs (116,353 3-year PSUs and 349,060 5-year PSUs).
  • PSUs vest based on relative TSR vs. S&P 500 over 3-year (June 1, 2026 - May 31, 2029) and 5-year (June 1, 2026 - May 31, 2031) performance periods.
  • Earned PSUs range from 0% to 250% of target based on relative TSR percentile, capped at 100% if absolute TSR is negative.
  • Post-vest transfer restrictions apply: 3-year PSUs locked for one year ending May 31, 2030; 50% of net 5-year PSUs locked for six months ending November 30, 2031.
  • The company reported a 275% total shareholder return over the last three fiscal years.

Financial Impact

No immediate financial impact; potential dilution of up to 930,826 shares (465,413 per co-CEO) at maximum 250% payout, but vesting is contingent on performance over 3-5 years.

dilution

Risk Factors

  • Potential dilution if PSUs vest at maximum 250% of target, adding up to 930,826 shares.
  • PSU performance conditions are tied to relative TSR, which may be affected by market conditions and sector performance.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
92% bullish (36 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-444416
Document: d457424d8k.htm0001193125-26-444416
Document: 0001193125-26-444416-index-headers.html0001193125-26-444416
Document: 0001193125-26-444416-index.html0001193125-26-444416
Document: 0001193125-26-444416.txt0001193125-26-444416

Track record

38 reports on GH

Performance horizon

3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +22.49% at T+60 after the May 27, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $145.04 Now $144.03 −0.70% settles Dec 16
  2. Nov 12, 20264d ago 3 Neutral 1/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
  3. Nov 12, 20264d ago 3 Neutral 2/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
  4. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $150.87 Now $144.03 −4.53% settles Dec 7
  5. Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $153.43 Now $144.03 −6.13% settles Dec 4
  6. Nov 3, 202613d ago 8-K Neutral 2/10 Entry $168.58 Now $144.03 −14.56% settles Dec 3
  7. Nov 3, 202613d ago 8-K Neutral 2/10 Viewing Entry $175.00 Now $144.03 −17.70% settles Dec 2
  8. Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $162.94 Now $144.03 −11.61% settles Nov 19
  9. Oct 14, 20264w ago 144 Neutral 2/10 Entry $165.88 to $154.86 Now $144.03 −13.17% ▼ −6.64% −4.74% vs SPY
  10. Sep 17, 20268w ago Insider Cluster Bearish 5/10 Entry $179.38 to $158.60 Now $144.03 +19.71% ▲ +11.58% +11.79% vs SPY
Showing 10 of 38

US Market Status

Market Closed · Opens in 7h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026